Edition:
United States

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

18.20USD
22 Sep 2017
Change (% chg)

$0.69 (+3.94%)
Prev Close
$17.51
Open
$17.41
Day's High
$18.41
Day's Low
$17.30
Volume
373,682
Avg. Vol
332,661
52-wk High
$18.53
52-wk Low
$6.11

Chart for

About

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive... (more)

Overall

Beta: 2.12
Market Cap(Mil.): $2,063.84
Shares Outstanding(Mil.): 113.40
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.67 16.08
EPS (TTM): -- -- --
ROI: -- 15.12 14.60
ROE: -- 16.35 14.03

BRIEF-Corcept Therapeutic says Dohmen Life Science Services filed a complaint alleging Corcept unlawfully terminated Dohmen agreement

* Corcept Therapeutics Inc - On August 7, 2017, Dohmen Life Science Services filed a complaint alleging corcept unlawfully terminated dohmen agreement

Aug 30 2017

BRIEF-Corcept Therapeutics Q2 GAAP earnings per share $0.10

* Corcept Therapeutics announces second quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update

Aug 01 2017

BRIEF-Corcept therapeutics Q1 GAAP earnings per share $0.04

* Corcept Therapeutics announces first quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update

May 01 2017

Competitors

Earnings vs. Estimates